Research Diagnosis Related Groups (DRG) level LOS quality outcomes for St. Joseph Hospital located at 4295 Hempstead Tpke, Bethpage, NY, 11714 & includes data from NPIs 1013998426
Dexur analyzed Q2 2018 (April to June 2018) Medicare claims data to benchmark length of stay (LOS) outcomes for St. Joseph Hospital compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
| Total Hospitalizations (Apr 2018 to Jun 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | New York Total Hospitalizations (Apr 2018 to Jun 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. LOS | National Total Hospitalizations (Apr 2018 to Jun 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Inpatient | 768 | 693 | ||||||||||
| Surgical | 116 | 112 | ||||||||||
| Non Surgical | 652 | 581 | ||||||||||
| General Medicine | 136 | 114 | ||||||||||
| Cardiovascular | 123 | 101 | ||||||||||
| Pulmonology | 115 | 104 | ||||||||||
| Gastroenterology & Endocrinology | 111 | 100 | ||||||||||
| Orthopedics | 90 | 89 | ||||||||||
| Urology | 68 | 67 | ||||||||||
| Neurology | 48 | 44 | ||||||||||
| General Surgery | 32 | 30 | ||||||||||
| Oncology & Hematology | 21 | 20 |
| Total Hospitalizations (Apr 2018 to Jun 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | New York Total Hospitalizations (Apr 2018 to Jun 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. LOS | National Total Hospitalizations (Apr 2018 to Jun 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Septicemia Or Severe Sepsis | ||||||||||||
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cellulitis | ||||||||||||
| DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Nutritional And Miscellaneous Metabolic Disorders |
| Total Hospitalizations (Apr 2018 to Jun 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | New York Total Hospitalizations (Apr 2018 to Jun 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. LOS | National Total Hospitalizations (Apr 2018 to Jun 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heart Failure And Shock | ||||||||||||
| DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cardiac Arrhythmia And Conduction Disorders | ||||||||||||
| Syncope And Collapse | ||||||||||||
| DRG 312: SYNCOPE AND COLLAPSE |
| Total Hospitalizations (Apr 2018 to Jun 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | New York Total Hospitalizations (Apr 2018 to Jun 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. LOS | National Total Hospitalizations (Apr 2018 to Jun 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chronic Obstructive Pulmonary Disease | ||||||||||||
| DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Simple Pneumonia And Pleurisy | ||||||||||||
| DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Respiratory Infections And Inflammations |
| Total Hospitalizations (Apr 2018 to Jun 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | New York Total Hospitalizations (Apr 2018 to Jun 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. LOS | National Total Hospitalizations (Apr 2018 to Jun 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
| DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| G.I.Hemorrhage | ||||||||||||
| DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Diabetes | ||||||||||||
| G.I. Obstruction |
| Total Hospitalizations (Apr 2018 to Jun 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | New York Total Hospitalizations (Apr 2018 to Jun 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. LOS | National Total Hospitalizations (Apr 2018 to Jun 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hip And Femur Procedures Except Major Joint | ||||||||||||
| DRG 481: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH COMPLICATION OR COMORBIDITY (CC) |
| Total Hospitalizations (Apr 2018 to Jun 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | New York Total Hospitalizations (Apr 2018 to Jun 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. LOS | National Total Hospitalizations (Apr 2018 to Jun 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Renal Failure | ||||||||||||
| DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Kidney And Urinary Tract Infections | ||||||||||||
| DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Apr 2018 to Jun 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | New York Total Hospitalizations (Apr 2018 to Jun 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. LOS | National Total Hospitalizations (Apr 2018 to Jun 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||
| Transient Ischemia | ||||||||||||
| DRG 069: TRANSIENT ISCHEMIA |
| Total Hospitalizations (Apr 2018 to Jun 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | New York Total Hospitalizations (Apr 2018 to Jun 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York Avg. LOS | National Total Hospitalizations (Apr 2018 to Jun 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Red Blood Cell Disorders | ||||||||||||
| DRG 812: RED BLOOD CELL DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |